BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) was the target of a significant drop in short interest in October. As of October 15th, there was short interest totalling 35,700 shares, a drop of 38.1% from the September 30th total of 57,700 shares. Based on an average trading volume of 30,300 shares, the days-to-cover ratio is presently 1.2 days.
BetterLife Pharma Stock Performance
OTCMKTS BETRF opened at $0.13 on Friday. The stock's 50 day simple moving average is $0.14 and its 200-day simple moving average is $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.
Get BetterLife Pharma alerts:BetterLife Pharma Company Profile
(Get Rating)
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.Read More
- Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
- Shopify Stock Price Surges as Losses Narrow, Investments Pay Off
- Will Demand from EV Makers Drive Up Freeport-McMoRan stock?
- MarketBeat: Week in Review 10/24-10/28
- McDonald's Stock Sizzles, but Will it Hit a New All-Time High?
- Apple Inc. Stock Q4 Results Beat Negative Outlook, Stock Rises
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.